The provision of care and life sciences

Investments into life sciences and the provision of care

Has there ever been a more poignant period in time that illustrates the importance of championing healthcare progress? In the midst of a global pandemic, healthcare technology has enabled the acceleration of vaccines and protected the most vulnerable. For those that live with health challenges every day, healthcare technology has ameliorated their lives, whether that is enabling them with a prosthetic limb or creating cells to give sight to the blind. Within our portfolio, healthcare relates to innovations within both the provision of care and also, within life sciences that provide the solutions to fundamentally improve patient outcomes. We focus on areas that we believe are shaping tomorrow’s healthcare market: Intervention to prevention, point of care, personalised, future pharma.

Meet the team

Related articles

Downing LLP launches 'knowledge intensive' EIS fund to fuel entrepreneurial healthcare businesses in wake of Covid-19

Specialist tax-efficient investment manager Downing LLP is pleased to announce the launch of a new Enterprise ...

How to survive and thrive in 2021 as a VC firm according to Downing Ventures - article

In 2021, it has never been more important for venture capital firms to be able to differentiate.

Why we invested in Carbice

The thermo-connectivity landscape needed a brave pioneer, a scientist and a brilliant mind to spin the whole i...